Megan Reed Evaurri

45 statements · 3 topics

Featured statements

TAC injections may be a safe, minimally invasive adjunct to traditional dilations with promising rates of stricture resolution and low short-term morbidity
70% of patients with anorectal malformations achieved stricture resolution with TAC injections
85% of patients with Hirschsprung disease achieved stricture resolution with TAC injections
TAC injections may be a useful treatment option before moving on to another operation
30% of anorectal malformation patients required surgery despite TAC injections
10% of Hirschsprung disease patients required surgery despite TAC injections

Nothing matches these filters — clear the search or widen the filters.

Megan's statements about Anorectal Malformation 15 statements

Open the Anorectal Malformation collection →

Safety and utility of long-acting steroid injection for management of post-operative stricture...

Quotation Do we have a safe way to reduce repeat procedures for patients with post-operative stricture after surgery for an anorectal malformation or Hirschprung disease? Open
Statement The study was published in 2026 in the Journal of Pediatric Surgery Open
Statement The study examined institutional experience from 2018 to 2024 Open
Statement 50 patients developed post-operative anastomotic stricture: 30 with anorectal malformations and 20 with Hirschsprung disease Open
Statement 70% of patients with anorectal malformations achieved stricture resolution with TAC injections Open
Statement 85% of patients with Hirschsprung disease achieved stricture resolution with TAC injections Open
Statement The median number of TAC injections needed to achieve stricture resolution was 1 in both groups Open
Statement 30% of anorectal malformation patients required surgery despite TAC injections Open
Statement 10% of Hirschsprung disease patients required surgery despite TAC injections Open
Statement The 30-day complication rate was 2.2% Open
Statement There were no intraoperative complications from TAC injections Open
Statement TAC injections may be a safe, minimally invasive adjunct to traditional dilations with promising rates of stricture resolution and low short-term morbidity Open
Statement TAC injections may be a useful treatment option before moving on to another operation Open
Statement This is a retrospective single center study Open
Quotation So, would this change the way that you manage post-operative recurrent anastomotic strictures at your institution? Open
Megan's statements about Colorectal / ARM & Hirschsprung 15 statements

Open the Colorectal / ARM & Hirschsprung collection →

Safety and utility of long-acting steroid injection for management of post-operative stricture...

Quotation Do we have a safe way to reduce repeat procedures for patients with post-operative stricture after surgery for an anorectal malformation or Hirschprung disease? Open
Statement The study was published in 2026 in the Journal of Pediatric Surgery Open
Statement The study examined institutional experience from 2018 to 2024 Open
Statement 50 patients developed post-operative anastomotic stricture: 30 with anorectal malformations and 20 with Hirschsprung disease Open
Statement 70% of patients with anorectal malformations achieved stricture resolution with TAC injections Open
Statement 85% of patients with Hirschsprung disease achieved stricture resolution with TAC injections Open
Statement The median number of TAC injections needed to achieve stricture resolution was 1 in both groups Open
Statement 30% of anorectal malformation patients required surgery despite TAC injections Open
Statement 10% of Hirschsprung disease patients required surgery despite TAC injections Open
Statement The 30-day complication rate was 2.2% Open
Statement There were no intraoperative complications from TAC injections Open
Statement TAC injections may be a safe, minimally invasive adjunct to traditional dilations with promising rates of stricture resolution and low short-term morbidity Open
Statement TAC injections may be a useful treatment option before moving on to another operation Open
Statement This is a retrospective single center study Open
Quotation So, would this change the way that you manage post-operative recurrent anastomotic strictures at your institution? Open
Megan's statements about Hirschsprung disease 15 statements

Open the Hirschsprung disease collection →

Safety and utility of long-acting steroid injection for management of post-operative stricture...

Quotation Do we have a safe way to reduce repeat procedures for patients with post-operative stricture after surgery for an anorectal malformation or Hirschprung disease? Open
Statement The study was published in 2026 in the Journal of Pediatric Surgery Open
Statement The study examined institutional experience from 2018 to 2024 Open
Statement 50 patients developed post-operative anastomotic stricture: 30 with anorectal malformations and 20 with Hirschsprung disease Open
Statement 70% of patients with anorectal malformations achieved stricture resolution with TAC injections Open
Statement 85% of patients with Hirschsprung disease achieved stricture resolution with TAC injections Open
Statement The median number of TAC injections needed to achieve stricture resolution was 1 in both groups Open
Statement 30% of anorectal malformation patients required surgery despite TAC injections Open
Statement 10% of Hirschsprung disease patients required surgery despite TAC injections Open
Statement There were no intraoperative complications from TAC injections Open
Statement The 30-day complication rate was 2.2% Open
Statement TAC injections may be a safe, minimally invasive adjunct to traditional dilations with promising rates of stricture resolution and low short-term morbidity Open
Statement TAC injections may be a useful treatment option before moving on to another operation Open
Statement This is a retrospective single center study Open
Quotation So, would this change the way that you manage post-operative recurrent anastomotic strictures at your institution? Open